Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,290 across all filing types
Latest filing 2020-06-15 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
独立董事关于第三届董事会第十四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Zhengzhou Antu Bioengineering Co., Ltd. regarding matters discussed at the 14th meeting of the third board of directors. The content focuses on the non-public issuance of shares, the feasibility of the fundraising plan, the use of previously raised funds, dilution of immediate returns and compensation measures, and the company's shareholder return plan for the next three years. It is a formal opinion on board meeting matters related to capital raising and shareholder interests, not a full financial report or earnings release. The document is relatively short (1533 characters) and is a formal board-related opinion rather than a report or announcement of a report. This fits best under Board/Management Information (MANG), which covers announcements of changes or opinions from the board or senior management on company matters.
2020-06-15 Chinese
前次募集资金鉴证报告
Regulatory Filings
2020-06-15 Chinese
2020年非公开发行股票预案
Capital/Financing Update Classification · 95% confidence The document is titled "2020年非公开发行股票预案" which translates to "2020 Non-public Issuance of Shares Proposal." It is a detailed plan regarding a non-public offering of shares by the company, including background, purpose, issuance details, pricing, target investors, and use of proceeds. The document discusses the issuance of new shares to specific investors, pricing mechanisms, limits on share quantity, and regulatory approvals required. This is a capital raising activity involving issuance of new shares, which fits the category of Capital/Financing Update (CAP). The document is lengthy (15,000 characters) and contains substantive details about the financing plan, not just an announcement or summary. Therefore, it is not a report publication announcement or a regulatory filing. It is not an annual or interim report, nor an earnings release or management discussion. It is clearly a detailed capital raising plan. Hence, the correct classification is CAP with high confidence.
2020-06-15 Chinese
关于最近五年未被证券监管部门和证券交易所采取监管措施或处罚情况的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Zhengzhou Antu Biological Engineering Co., Ltd. stating that in the past five years, the company has not been subject to any regulatory measures or penalties by securities regulatory authorities or stock exchanges. It mentions the company's intention to apply for a non-public stock issuance. The document is brief (375 characters) and serves as a regulatory compliance statement rather than a detailed report or financial statement. It does not contain financial data, management changes, or voting results. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-06-15 Chinese
关于前次募集资金使用情况报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the usage of previously raised funds by Zhengzhou Antu Biological Engineering Co., Ltd. It includes specifics on amounts raised through stock issuance and convertible bonds, the status of funds, investment projects, changes in project implementation, and the effectiveness of investments. The document references regulatory requirements from the China Securities Regulatory Commission and includes detailed tables on fund usage and project outcomes. It is not a general annual or quarterly report, nor is it an earnings release or a management discussion. It specifically focuses on the use of previously raised capital, which aligns with the category of Capital/Financing Update (CAP). The document is substantive and detailed, not a brief announcement or certification, so it is not RPA or RNS. Therefore, the best classification is CAP with high confidence.
2020-06-15 Chinese
关于召开2020年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for convening the 2020 first extraordinary general meeting of shareholders of Zhengzhou Antu Bioengineering Co., Ltd. It details the meeting date, voting methods, agenda items, and procedural instructions for shareholders. It does not contain financial statements or results but is an announcement about the meeting and the voting process. The document length is under 5,000 characters and primarily serves as a meeting notice rather than a report or results announcement. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-06-15 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.